(cache)NCBI Blast:ref|NZ_JAACYR010000216.1|

Save Search

Search Parameters
Search parameter name	Search parameter value
Program	blastn
Word size	28
Expect value	0.05
Hitlist size	500
Match/Mismatch scores	1,-2
Gapcosts	0,2.5
Low Complexity Filter	Yes
Filter string	L;m;
Genetic Code	1

Database
Database parameter name	Database parameter value
Posted date	Jan 22, 2025 12:59 PM
Number of letters	28,243,478,142
Number of sequences	48,926,134
Entrez query	Includes: Excludes: None

Karlin-Altschul statistics
Params	Ungapped	Gapped
Lambda	1.33271	1.28
K	0.620991	0.46
H	1.12409	0.85

Results Statistics
Results Statistics parameter name	Results Statistics parameter value
Length adjustment	32
Effective length of query	344
Effective length of database	26677841854
Effective search space	9177177597776
Effective search space used	9177177597776

Job Title

ref|NZ_JAACYR010000216.1| ...

RID

T9YVKGA5013 Search expires on 01-26 21:55 pm

Download All

Results for

Program

BLASTN

Citation

Database

pat

See details

Query ID

NZ_JAACYR010000216.1

Description

Mycolicibacter kumamotonensis strain CST 7247 NODE_216_length_376_cov_1.348910, whole genome shotgun sequence ...

Molecule type

dna

Query Length

376

Other reports

Distance tree of results MSA viewer

Filter Results

Descriptions

select all
100 sequences selected

, Reading indexes 1-5, displaying indexes 1-5, Reading indexes 6-10, displaying indexes 6-10

Sequences producing significant alignments:
Select for downloading or viewing reports	Description	Scientific Name	Common Name	Taxid	Max Score	Total Score	Query Cover	E value	Per. Ident	Acc. Len	Accession
1Select seq PB192378.1	JP 2020504764-A/5522: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB192378.1
2Select seq PB190482.1	JP 2020504764-A/3626: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB190482.1
3Select seq PB190481.1	JP 2020504764-A/3625: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB190481.1
4Select seq PB189962.1	JP 2020504764-A/3106: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189962.1
5Select seq PB189960.1	JP 2020504764-A/3104: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189960.1
6Select seq PB189642.1	JP 2020504764-A/2786: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189642.1
7Select seq PB189640.1	JP 2020504764-A/2784: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189640.1
8Select seq PB189637.1	JP 2020504764-A/2781: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189637.1
9Select seq PB189533.1	JP 2020504764-A/2677: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189533.1
10Select seq PB189500.1	JP 2020504764-A/2644: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189500.1
11Select seq PB189481.1	JP 2020504764-A/2625: mRNA vaccines	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1698	PB189481.1
12Select seq MM853540.1	Sequence 68 from patent US 10272148			0	601	601	100%	9e-169	95.48%	3079	MM853540.1
13Select seq MM853539.1	Sequence 67 from patent US 10272148			0	601	601	100%	9e-169	95.48%	1719	MM853539.1
14Select seq MM853538.1	Sequence 66 from patent US 10272148			0	601	601	100%	9e-169	95.48%	3058	MM853538.1
15Select seq MM853533.1	Sequence 61 from patent US 10272148			0	601	601	100%	9e-169	95.48%	3185	MM853533.1
16Select seq MM853532.1	Sequence 60 from patent US 10272148			0	601	601	100%	9e-169	95.48%	1788	MM853532.1
17Select seq MM608379.1	Sequence 105 from patent US 10190132			0	601	601	100%	9e-169	95.48%	3079	MM608379.1
18Select seq MM608378.1	Sequence 104 from patent US 10190132			0	601	601	100%	9e-169	95.48%	3058	MM608378.1
19Select seq MM608360.1	Sequence 86 from patent US 10190132			0	601	601	100%	9e-169	95.48%	3206	MM608360.1
20Select seq MM608339.1	Sequence 62 from patent US 10190132			0	601	601	100%	9e-169	95.48%	3088	MM608339.1
21Select seq MM608325.1	Sequence 36 from patent US 10190132			0	601	601	100%	9e-169	95.48%	1788	MM608325.1
22Select seq LX264100.1	JP 2016032477-A/34: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1788	LX264100.1
23Select seq LX264153.1	JP 2016032477-A/87: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3058	LX264153.1
24Select seq LX264154.1	JP 2016032477-A/88: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3079	LX264154.1
25Select seq LX264114.1	JP 2016032477-A/48: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3088	LX264114.1
26Select seq LX264135.1	JP 2016032477-A/69: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3206	LX264135.1
27Select seq LX269787.1	JP 2016052331-A/88: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3079	LX269787.1
28Select seq LX269786.1	JP 2016052331-A/87: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3058	LX269786.1
29Select seq LX269768.1	JP 2016052331-A/69: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3206	LX269768.1
30Select seq LX269747.1	JP 2016052331-A/48: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3088	LX269747.1
31Select seq LX269733.1	JP 2016052331-A/34: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1788	LX269733.1
32Select seq KH355857.1	Sequence 105 from patent US 9492528			0	601	601	100%	9e-169	95.48%	3079	KH355857.1
33Select seq KH355856.1	Sequence 104 from patent US 9492528			0	601	601	100%	9e-169	95.48%	3058	KH355856.1
34Select seq KH355838.1	Sequence 86 from patent US 9492528			0	601	601	100%	9e-169	95.48%	3206	KH355838.1
35Select seq KH355817.1	Sequence 62 from patent US 9492528			0	601	601	100%	9e-169	95.48%	3088	KH355817.1
36Select seq KH355803.1	Sequence 36 from patent US 9492528			0	601	601	100%	9e-169	95.48%	1788	KH355803.1
37Select seq KH277900.1	Sequence 105 from patent US 9458470			0	601	601	100%	9e-169	95.48%	3079	KH277900.1
38Select seq KH277899.1	Sequence 104 from patent US 9458470			0	601	601	100%	9e-169	95.48%	3058	KH277899.1
39Select seq KH277881.1	Sequence 86 from patent US 9458470			0	601	601	100%	9e-169	95.48%	3206	KH277881.1
40Select seq KH277860.1	Sequence 62 from patent US 9458470			0	601	601	100%	9e-169	95.48%	3088	KH277860.1
41Select seq KH277846.1	Sequence 36 from patent US 9458470			0	601	601	100%	9e-169	95.48%	1788	KH277846.1
42Select seq HL994430.1	Sequence 62 from patent US 9452210			0	601	601	100%	9e-169	95.48%	3088	HL994430.1
43Select seq HL994416.1	Sequence 36 from patent US 9452210			0	601	601	100%	9e-169	95.48%	1788	HL994416.1
44Select seq LG253532.1	KR 1020160049061-A/105: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3079	LG253532.1
45Select seq LG253531.1	KR 1020160049061-A/104: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3058	LG253531.1
46Select seq LG253513.1	KR 1020160049061-A/86: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3206	LG253513.1
47Select seq LG253492.1	KR 1020160049061-A/62: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3088	LG253492.1
48Select seq LG253478.1	KR 1020160049061-A/36: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1788	LG253478.1
49Select seq HZ418948.1	JP 2014097076-A/69: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3206	HZ418948.1
50Select seq HZ418927.1	JP 2014097076-A/48: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3088	HZ418927.1
51Select seq HZ418913.1	JP 2014097076-A/34: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1788	HZ418913.1
52Select seq HZ418967.1	JP 2014097076-A/88: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3079	HZ418967.1
53Select seq HZ418966.1	JP 2014097076-A/87: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3058	HZ418966.1
54Select seq HW635162.1	JP 2014158483-A/68: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3079	HW635162.1
55Select seq HW635161.1	JP 2014158483-A/67: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1719	HW635161.1
56Select seq HW635160.1	JP 2014158483-A/66: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3058	HW635160.1
57Select seq HW635155.1	JP 2014158483-A/61: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3185	HW635155.1
58Select seq HW635154.1	JP 2014158483-A/60: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1788	HW635154.1
59Select seq HW081523.1	JP 2012530499-A/61: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3185	HW081523.1
60Select seq HW081529.1	JP 2012530499-A/67: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1719	HW081529.1
61Select seq JA483942.1	Sequence 105 from Patent EP2307549	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3079	JA483942.1
62Select seq JA483941.1	Sequence 104 from Patent EP2307549	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3058	JA483941.1
63Select seq JA483923.1	Sequence 86 from Patent EP2307549	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3206	JA483923.1
64Select seq HI547155.1	Sequence 62 from Patent EP2173886	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	3088	HI547155.1
65Select seq HI547129.1	Sequence 36 from Patent EP2173886	synthetic construct	NA	32630	601	601	100%	9e-169	95.48%	1788	HI547129.1
66Select seq PB192873.1	JP 2020504764-A/6017: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192873.1
67Select seq PB192870.1	JP 2020504764-A/6014: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192870.1
68Select seq PB192867.1	JP 2020504764-A/6011: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192867.1
69Select seq PB192863.1	JP 2020504764-A/6007: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192863.1
70Select seq PB192852.1	JP 2020504764-A/5996: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192852.1
71Select seq PB192838.1	JP 2020504764-A/5982: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192838.1
72Select seq PB192834.1	JP 2020504764-A/5978: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192834.1
73Select seq PB192821.1	JP 2020504764-A/5965: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192821.1
74Select seq PB192808.1	JP 2020504764-A/5952: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192808.1
75Select seq PB192798.1	JP 2020504764-A/5942: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192798.1
76Select seq PB192797.1	JP 2020504764-A/5941: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB192797.1
77Select seq PB190968.1	JP 2020504764-A/4112: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190968.1
78Select seq PB190967.1	JP 2020504764-A/4111: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190967.1
79Select seq PB190966.1	JP 2020504764-A/4110: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190966.1
80Select seq PB190965.1	JP 2020504764-A/4109: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190965.1
81Select seq PB190963.1	JP 2020504764-A/4107: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190963.1
82Select seq PB190962.1	JP 2020504764-A/4106: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190962.1
83Select seq PB190956.1	JP 2020504764-A/4100: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190956.1
84Select seq PB190955.1	JP 2020504764-A/4099: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190955.1
85Select seq PB190954.1	JP 2020504764-A/4098: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190954.1
86Select seq PB190951.1	JP 2020504764-A/4095: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190951.1
87Select seq PB190810.1	JP 2020504764-A/3954: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190810.1
88Select seq PB190808.1	JP 2020504764-A/3952: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190808.1
89Select seq PB190807.1	JP 2020504764-A/3951: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190807.1
90Select seq PB190804.1	JP 2020504764-A/3948: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB190804.1
91Select seq PB188893.1	JP 2020504764-A/2037: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB188893.1
92Select seq PB197259.1	JP 2020504764-A/10403: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB197259.1
93Select seq PB196000.1	JP 2020504764-A/9144: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB196000.1
94Select seq PB195998.1	JP 2020504764-A/9142: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB195998.1
95Select seq PB195997.1	JP 2020504764-A/9141: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB195997.1
96Select seq PB195772.1	JP 2020504764-A/8916: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB195772.1
97Select seq PB195771.1	JP 2020504764-A/8915: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB195771.1
98Select seq PB195669.1	JP 2020504764-A/8813: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB195669.1
99Select seq PB195660.1	JP 2020504764-A/8804: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB195660.1
100Select seq PB194658.1	JP 2020504764-A/7802: mRNA vaccines	synthetic construct	NA	32630	595	595	100%	4e-167	95.21%	1698	PB194658.1

- hover to see the title
- click to show alignments
- Show Conserved Domains
- Alignment Scores
- < 40
- 40 - 50
- 50 - 80
- 80 - 200
- >= 200
- Help
  The graphic is an overview of the database sequences aligned to the query sequence. These are represented horizontal bars colored coded by score and showing the extent of the alignment on the query sequence. Separate aligned regions on the same database sequence are connected by a thin grey line. Mousing over an alignment shows the database sequence title. Clicking an alignment displays a box with more details about the alignment and link to the sequence alignment itself in the Alignments section of the report.
- 100 sequences selected
- Help
Distribution of the top 100 Blast Hits on 100 subject sequences

Query

1
70
140
210
280
350

Alignments

100 sequences selected
Help

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/5522: mRNA vaccines

Sequence ID: PB192378.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             | |||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TAAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATACTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/3626: mRNA vaccines

Sequence ID: PB190482.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct  1406  TAAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/3625: mRNA vaccines

Sequence ID: PB190481.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/3106: mRNA vaccines

Sequence ID: PB189962.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/3104: mRNA vaccines

Sequence ID: PB189960.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/2786: mRNA vaccines

Sequence ID: PB189642.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/2784: mRNA vaccines

Sequence ID: PB189640.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/2781: mRNA vaccines

Sequence ID: PB189637.1Length: 1698Number of Matches: 1

See 1 more title(s) See all Identical Proteins(IPG)

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/2677: mRNA vaccines

Sequence ID: PB189533.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Download GenBank Graphics Next Previous Descriptions

JP 2020504764-A/2644: mRNA vaccines

Sequence ID: PB189500.1Length: 1698Number of Matches: 1

Range 1: 1286 to 1661GenBank Graphics Next Match Previous Match

Alignment statistics for match #1
Score	Expect	Identities	Gaps	Strand	Frame
601 bits(325)	9e-169()	359/376(95%)	0/376(0%)	Plus/Plus

Query  1     ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGATTCTACTGGAAAATGAAA  60
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||
Sbjct  1286  ATGGGTTTATAGACATTTGGACATATAATGCAGAACTGTTGGTTCTACTGGAAAATGAAA  1345

Query  61    GGACTTTGGATTTCCATGATTCCAATGTGAAGAATCTTTATGAGAAAGTAAAAAGCCAGT  120
             ||||||||||||||||||| ||||||||||||||||| ||||||||||||||||||||||
Sbjct  1346  GGACTTTGGATTTCCATGACTCCAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAGT  1405

Query  121   TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAGTTCTATCACAAGTGTAACG  180
             |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||
Sbjct  1406  TGAAGAATAATGCTAAAGAAATAGGAAATGGGTGTTTTGAATTCTATCACAAGTGTAACG  1465

Query  181   ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTACCCAAAATACTCCGAGGAAT  240
             |||||||||||||||||||||||||||||||||||||||| |||||||| ||||| ||||
Sbjct  1466  ATGAATGCATGGAGAGTGTAAAGAATGGAACTTATGACTATCCAAAATATTCCGAAGAAT  1525

Query  241   CAAAGCTAAACAGGGAGGAAATTGATGGAGTGAGATTGGAATCAATGGGAATCTATCAGA  300
             ||||| ||||||||||| ||||||||||||||| |||||||||||||||| |||||||||
Sbjct  1526  CAAAGTTAAACAGGGAGAAAATTGATGGAGTGAAATTGGAATCAATGGGAGTCTATCAGA  1585

Query  301   TTCTGGCAATCTACTCAACAGTCGCCAGTTCTATTGTTCTTTTCGTCTCCCTGGGGGCAA  360
             ||||||| |||||||||||||||||||||||| | |||||||| ||||||||||||||||
Sbjct  1586  TTCTGGCGATCTACTCAACAGTCGCCAGTTCTCTGGTTCTTTTGGTCTCCCTGGGGGCAA  1645

Query  361   TCACCTTTTGGATGTG  376
             ||| ||| ||||||||
Sbjct  1646  TCAGCTTCTGGATGTG  1661

Taxonomy

100 sequences selected
Help

Lineage

Lineage Report
Organism	Blast Name	Score	Number of Hits	Description
other sequences	other sequences		140
.artificial sequences	other sequences		12
..synthetic construct	other sequences	601	128	synthetic construct hits
.artificial sequences	other sequences	601	12	artificial sequences hits

Organism

Organism Report
Description	Score	E value	Accession
synthetic construct [other sequences] Next Previous First
JP 2020504764-A/5522: mRNA vaccines	601	9e-169	PB192378
JP 2020504764-A/3626: mRNA vaccines	601	9e-169	PB190482
JP 2020504764-A/3625: mRNA vaccines	601	9e-169	PB190481
JP 2020504764-A/3106: mRNA vaccines	601	9e-169	PB189962
JP 2020504764-A/3104: mRNA vaccines	601	9e-169	PB189960
JP 2020504764-A/2786: mRNA vaccines	601	9e-169	PB189642
JP 2020504764-A/2784: mRNA vaccines	601	9e-169	PB189640
JP 2020504764-A/2781: mRNA vaccines	601	9e-169	PB189637
JP 2020504764-A/3099: mRNA vaccines	601	9e-169	PB189955
JP 2020504764-A/2677: mRNA vaccines	601	9e-169	PB189533
JP 2020504764-A/2644: mRNA vaccines	601	9e-169	PB189500
JP 2020504764-A/2625: mRNA vaccines	601	9e-169	PB189481
JP 2016032477-A/34: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	LX264100
JP 2016032477-A/87: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	LX264153
JP 2016032477-A/88: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	LX264154
JP 2016032477-A/48: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	LX264114
JP 2016032477-A/69: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	LX264135
JP 2016052331-A/88: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	LX269787
JP 2016052331-A/87: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	LX269786
JP 2016052331-A/69: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	LX269768
JP 2016052331-A/48: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	LX269747
JP 2016052331-A/34: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	LX269733
KR 1020160049061-A/105: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	LG253532
KR 1020160049061-A/104: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	LG253531
KR 1020160049061-A/86: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	LG253513
KR 1020160049061-A/62: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	LG253492
KR 1020160049061-A/36: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES(VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	LG253478
JP 2014097076-A/69: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HZ418948
JP 2014097076-A/48: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HZ418927
JP 2014097076-A/34: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HZ418913
JP 2014097076-A/88: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HZ418967
JP 2014097076-A/87: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HZ418966
JP 2014158483-A/68: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW635162
JP 2014158483-A/67: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW635161
JP 2014158483-A/66: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW635160
JP 2014158483-A/61: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW635155
JP 2014158483-A/60: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW635154
JP 2012530499-A/61: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW081523
KR 1020120133371-A/61: CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES COMPRISING HEMAGGLUTININ	601	9e-169	DI343324
Sequence 61 from Patent EP3228627	601	9e-169	LP947166
JP 2012530499-A/67: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW081529
KR 1020120133371-A/67: CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES COMPRISING HEMAGGLUTININ	601	9e-169	DI343330
Sequence 67 from Patent EP3228627	601	9e-169	LP947172
Sequence 105 from Patent EP2307549	601	9e-169	JA483942
JP 2011527180-A/88: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	HV549872
JP 2011509661-A/88: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HV931471
JP 2012530499-A/68: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW081530
Sequence 105 from Patent EP2570484	601	9e-169	JB243002
Sequence 105 from Patent EP2610345	601	9e-169	JB623756
KR 1020120133371-A/68: CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES COMPRISING HEMAGGLUTININ	601	9e-169	DI343331
Sequence 68 from Patent EP3228627	601	9e-169	LP947173
Sequence 104 from Patent EP2307549	601	9e-169	JA483941
JP 2011527180-A/87: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	HV549871
JP 2011509661-A/87: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HV931470
JP 2012530499-A/66: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW081528
Sequence 104 from Patent EP2570484	601	9e-169	JB243001
Sequence 104 from Patent EP2610345	601	9e-169	JB623755
KR 1020120133371-A/66: CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES COMPRISING HEMAGGLUTININ	601	9e-169	DI343329
Sequence 66 from Patent EP3228627	601	9e-169	LP947171
Sequence 86 from Patent EP2307549	601	9e-169	JA483923
JP 2011527180-A/69: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	HV549853
JP 2011509661-A/69: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HV931452
Sequence 86 from Patent EP2570484	601	9e-169	JB242983
Sequence 86 from Patent EP2610345	601	9e-169	JB623737
Sequence 62 from Patent EP2173886	601	9e-169	HI547155
JP 2010533001-A/48: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	FW582333
Sequence 62 from Patent EP2307549	601	9e-169	JA483899
JP 2011527180-A/48: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	HV549832
JP 2011509661-A/48: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HV931431
Sequence 62 from Patent EP2570484	601	9e-169	JB242959
Sequence 62 from Patent EP2610345	601	9e-169	JB623713
Sequence 36 from Patent EP2173886	601	9e-169	HI547129
JP 2010533001-A/34: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	FW582319
Sequence 36 from Patent EP2307549	601	9e-169	JA483873
JP 2011527180-A/34: Influenza Virus-Like Particles (VLPS) Comprising Hemagglutinin	601	9e-169	HV549818
JP 2011509661-A/34: Recombinant Influenza Virus-Like Particles (VLPS) Produced in Transgenic Plants Expressing Hemagglutinin	601	9e-169	HV931417
JP 2012530499-A/60: Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin	601	9e-169	HW081522
Sequence 36 from Patent EP2570484	601	9e-169	JB242933
Sequence 36 from Patent EP2610345	601	9e-169	JB623687
KR 1020120133371-A/60: CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES COMPRISING HEMAGGLUTININ	601	9e-169	DI343323
Sequence 60 from Patent EP3228627	601	9e-169	LP947165
JP 2020504764-A/6017: mRNA vaccines	595	4e-167	PB192873
JP 2020504764-A/6014: mRNA vaccines	595	4e-167	PB192870
JP 2020504764-A/6015: mRNA vaccines	595	4e-167	PB192871
JP 2020504764-A/6011: mRNA vaccines	595	4e-167	PB192867
JP 2020504764-A/6007: mRNA vaccines	595	4e-167	PB192863
JP 2020504764-A/5996: mRNA vaccines	595	4e-167	PB192852
JP 2020504764-A/5982: mRNA vaccines	595	4e-167	PB192838
JP 2020504764-A/5978: mRNA vaccines	595	4e-167	PB192834
JP 2020504764-A/5965: mRNA vaccines	595	4e-167	PB192821
JP 2020504764-A/5987: mRNA vaccines	595	4e-167	PB192843
JP 2020504764-A/6000: mRNA vaccines	595	4e-167	PB192856
JP 2020504764-A/5952: mRNA vaccines	595	4e-167	PB192808
JP 2020504764-A/5985: mRNA vaccines	595	4e-167	PB192841
JP 2020504764-A/5993: mRNA vaccines	595	4e-167	PB192849
JP 2020504764-A/6006: mRNA vaccines	595	4e-167	PB192862
JP 2020504764-A/6008: mRNA vaccines	595	4e-167	PB192864
JP 2020504764-A/6009: mRNA vaccines	595	4e-167	PB192865
JP 2020504764-A/5942: mRNA vaccines	595	4e-167	PB192798
JP 2020504764-A/5986: mRNA vaccines	595	4e-167	PB192842
JP 2020504764-A/5941: mRNA vaccines	595	4e-167	PB192797
JP 2020504764-A/4112: mRNA vaccines	595	4e-167	PB190968
JP 2020504764-A/4111: mRNA vaccines	595	4e-167	PB190967
JP 2020504764-A/4110: mRNA vaccines	595	4e-167	PB190966
JP 2020504764-A/5971: mRNA vaccines	595	4e-167	PB192827
JP 2020504764-A/5974: mRNA vaccines	595	4e-167	PB192830
JP 2020504764-A/4109: mRNA vaccines	595	4e-167	PB190965
JP 2020504764-A/4107: mRNA vaccines	595	4e-167	PB190963
JP 2020504764-A/4106: mRNA vaccines	595	4e-167	PB190962
JP 2020504764-A/4100: mRNA vaccines	595	4e-167	PB190956
JP 2020504764-A/4099: mRNA vaccines	595	4e-167	PB190955
JP 2020504764-A/4098: mRNA vaccines	595	4e-167	PB190954
JP 2020504764-A/4095: mRNA vaccines	595	4e-167	PB190951
JP 2020504764-A/3954: mRNA vaccines	595	4e-167	PB190810
JP 2020504764-A/3952: mRNA vaccines	595	4e-167	PB190808
JP 2020504764-A/3951: mRNA vaccines	595	4e-167	PB190807
JP 2020504764-A/3948: mRNA vaccines	595	4e-167	PB190804
JP 2020504764-A/2037: mRNA vaccines	595	4e-167	PB188893
JP 2020504764-A/10403: mRNA vaccines	595	4e-167	PB197259
JP 2020504764-A/9144: mRNA vaccines	595	4e-167	PB196000
JP 2020504764-A/9142: mRNA vaccines	595	4e-167	PB195998
JP 2020504764-A/9143: mRNA vaccines	595	4e-167	PB195999
JP 2020504764-A/9141: mRNA vaccines	595	4e-167	PB195997
JP 2020504764-A/8916: mRNA vaccines	595	4e-167	PB195772
JP 2020504764-A/8915: mRNA vaccines	595	4e-167	PB195771
JP 2020504764-A/8813: mRNA vaccines	595	4e-167	PB195669
JP 2020504764-A/8804: mRNA vaccines	595	4e-167	PB195660
JP 2020504764-A/7802: mRNA vaccines	595	4e-167	PB194658
artificial sequences [other sequences] Next Previous First
KR 1020110034650-A/105: INFLUENZA VIRUS-LIKE PARTICLES(VLPS) COMPRISING HEMAGGLUTININ	601	9e-169	DI222480
KR 1020100120157-A/105: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	DI211456
KR 1020110034650-A/104: INFLUENZA VIRUS-LIKE PARTICLES(VLPS) COMPRISING HEMAGGLUTININ	601	9e-169	DI222479
KR 1020100120157-A/104: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	DI211455
KR 1020110034650-A/86: INFLUENZA VIRUS-LIKE PARTICLES(VLPS) COMPRISING HEMAGGLUTININ	601	9e-169	DI222461
KR 1020100120157-A/86: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	DI211437
KR 1020110034650-A/62: INFLUENZA VIRUS-LIKE PARTICLES(VLPS) COMPRISING HEMAGGLUTININ	601	9e-169	DI222440
KR 1020100032920-A/62: INFLUENZA VIRUS-LIKE PARTICLES(VLPs) COMPRISING	601	9e-169	DI208376
KR 1020100120157-A/62: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	DI211416
KR 1020110034650-A/36: INFLUENZA VIRUS-LIKE PARTICLES(VLPS) COMPRISING HEMAGGLUTININ	601	9e-169	DI222426
KR 1020100032920-A/36: INFLUENZA VIRUS-LIKE PARTICLES(VLPs) COMPRISING	601	9e-169	DI208362
KR 1020100120157-A/36: RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPs) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ	601	9e-169	DI211402

Taxonomy

Taxonomy Report
Taxonomy	Number of hits	Number of Organisms	Description
other sequences	140	2
. artificial sequences	12	2	artificial sequences hits
.. synthetic construct	128	1	synthetic construct hits

Filter Results

Sequences producing significant alignments